Found: 3 articles
Article | Edition |
---|---|
A.V. Fateeva, E.V. Eliseeva, V.I. Apanasevich, A.A. Zaemskaya
Analysis of pharmacotherapy in patients with HR+HER2- metastatic breast cancer with PIK3CA mutations in real clinical practice
|
№7 / 2024 |
R.V. Orlova (1, 2), A.A. Vakhitova (1, 2), M.I. Gluzman (1, 2)
New possibilities of neoadjuvant treatment of ER+ HER2- breast cancer in premenopausal patients
|
№7 / 2021 |
A.V. Fateeva (1), A.V.Zyuzyukina (2), R.A. Zukov (2)
A clinical case of using ribociclib with an aromatase inhibitor in metastatic hormone-receptor-positive HER2-negative breast cancer with a rare location of metastasis
|
№12 / 2019 |